Terry Fox funding supports two research projects

The Terry Fox Research Institute (TFRI) is investing $13.4 million in two established research teams focused on oncolytic viruses and leukemia. The funding flows through TFRI's New Frontiers Program Project Grants, the Terry Fox Foundation's flagship program. An Ottawa-based team led by Dr John Bell, a senior scientist at the Ottawa Hospital Research Institute, will receive $7.5 million to fund its trans-Canada network examining the use of oncolytic viruses as biotherapeutics to treat cancer. The funding includes $500,000 from the Canadian Institutes of Health Research, which assisted TFRI in managing the selection and review of the successful programs. A Vancouver-based team at the BC Cancer Agency will receive $5.9 million to develop new ways of treating aggressive forms of leukemia by creating and using laboratory-built models that mimic human acute leukemia....